Friday, July 10, 2026

pharma · Pompe Disease (Late-onset) · Fabry Disease

Pacalis Therapeutics Pty

Pacalis Therapeutics Pty trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

melbourne, AU HQ
2023 Founded
1 Employees
TGA registrant Type
Company details
Status
Public
HQ
melbourne, AU
Founded
2023
Employees
1
Programs
5
Drugs
6
Patents
0
Intelligence · Clinical Trials

Pacalis Therapeutics Pty clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Pacalis Therapeutics Pty programs — each row shows trial ID, program name, phase, status, and indication.

Pacalis Therapeutics Pty trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Pacalis Therapeutics Pty.

  1. Cipaglucosidase Alfa — Phase 3

    Clinical update
  2. Migalastat Hydrochloride Dispersible Tablet — Phase 3

    Clinical update
  3. AT2221 — Phase 3

    Clinical update
  4. migalastat HCl 150 mg — Phase 3

    Clinical update
  5. AT2221, ATB200 — Phase 3

    Clinical update

Trial registry

5 studies